Treatment of inflammatory intestinal diseases (Crohn's disease, ulcerative colitis) using genetically engineered drugs
Multicomponent therapy for ulcerative colitis and Crohn’s disease 3 and 4 degrees of activity, hormone-dependent and hormone-resistant forms is carried out by chemotherapeutic and genetic engineering biological drugs under guidance of immunological, morphological, histochemical and instrumental studies.